Retinal Vascular Changes During Pregnancy
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT06311617
- Status
- Recruiting
Conditions
- Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Optical coherence tomography — DIAGNOSTIC_TESTNon-mydriatic fundus photography and optical coherence tomography will be performed at 3 timepoints
Study Details
The goal of this study is to better understand how the back part of the eye-called the retina and the choroid-changes during pregnancy. Specialized photos of the eye will be taken at three different timepoints: early in pregnancy (first or second trimester), late in pregnancy (third trimester), and after delivery. This imaging is non-invasive and does not require contact with the surface of the eye. The photos taken will allow assessment of specific parameters, like blood flow and the health of specialized cells that support vision. Understanding how the eyes change during pregnancy may help guide how retina specialists understanding of retinal disease during pregnancy and better inform pregnancy outcomes.
Key Dates
- Start date
- Feb 1, 2024
- Status verified
- May 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 90 participants (estimated)
Arms
- Arm: Healthy Pregnant PatientsHealth pregnancies
- Arm: Pregnant Patients with Pre-Existing DiabetesPatients with pre-existing diabetes who are pregnant
- Arm: Pregnant Patients with Vascular Disease or Risk Factors for Vascular Disease1. Multiple gestations 2. Preeclampsia or eclampsia 3. Gestational diabetes 4. Hypercoagulable state such as disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome.
Primary Outcome Measure
Imaging Biomarkers: Choroid [ Time Frame: during 9 months of pregnancy and in the 3 months after pregnancy ]
Central Contacts
- Saige Priddy615-936-2020
- Elise Timtim, MD615-936-2020
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Avni Finn, MD, MBA 615-936-1639 |
Find similar trials in Nashville, TN
Related Studies
- Pregnancies Complicated by Fetal AnomaliesRecruiting · University of Tennessee · Memphis, Tennessee
- Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsiaRecruiting · University of Tennessee Graduate School of Medicine · Knoxville, Tennessee
- Cardiometabolic Disease and Substrate MetabolismRecruiting · University of Tennessee Graduate School of Medicine · Knoxville, Tennessee
- Effects of Oncological Treatment During Pregnancy on Mother and ChildRecruiting · University Hospital, Gasthuisberg · Camden, New Jersey